![Currie Gavin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Currie Gavin
Founder at Biosceptre (Aust) Pty Ltd.
Currie Gavin active positions
Companies | Position | Start | End |
---|---|---|---|
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
Founder | - | - | |
Prescare
![]() Prescare Miscellaneous Commercial ServicesCommercial Services Prescare provides care services including residential, in-home community care and chaplaincy and pastoral care. It offers residential and dementia care, affordable housing, day therapy centre, respite care and social programs. The company is headquartered in Milton, Australia. | Director/Board Member | - | - |
Career history of Currie Gavin
Former positions of Currie Gavin
Companies | Position | Start | End |
---|---|---|---|
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Director/Board Member | - | - |
Chief Executive Officer | 01/10/2012 | - |
Statistics
International
Australia | 3 |
United Kingdom | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Founder | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Health Technology |
Prescare
![]() Prescare Miscellaneous Commercial ServicesCommercial Services Prescare provides care services including residential, in-home community care and chaplaincy and pastoral care. It offers residential and dementia care, affordable housing, day therapy centre, respite care and social programs. The company is headquartered in Milton, Australia. | Commercial Services |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Health Technology |
- Stock Market
- Insiders
- Currie Gavin
- Experience